| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 06/19/2007 | US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 06/19/2007 | US7232792 3-heterocyclyl-substituted benzoyl derivatives |
| 06/19/2007 | US7232616 Complex |
| 06/14/2007 | WO2007067501A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
| 06/14/2007 | WO2007066617A1 Condensation reaction by metal catalyst |
| 06/14/2007 | WO2007065828A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 06/14/2007 | WO2007065821A1 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | US20070135633 producing pyridine-substituted indole compound by reacting an indole with pyridine having leaving group, in presence of heterogeneous-system platinum group metal catalyst on support, ligand (1,1'-bis(diphenylphosphino)ferrocene) and base; industrial scale, cost efficiency |
| 06/14/2007 | US20070135501 Amino acid derivatives |
| 06/14/2007 | US20070135500 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | US20070135496 Substituted benzylaminoalkylene heterocycles |
| 06/14/2007 | US20070135447 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors |
| 06/14/2007 | US20070135357 Anti-hypercholesterolemic compounds |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | DE102005027589B3 Temperatur-/Bestrahlungs-/Polymerisationsindikatoren Temperature / radiation / Polymerisationsindikatoren |
| 06/14/2007 | CA2632531A1 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | CA2632109A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 06/14/2007 | CA2629609A1 Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols |
| 06/13/2007 | EP1794117A2 Mercaptoamides as histone deacetylase inhibitors |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | CN1980904A CETP inhibitors |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7229998 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/07/2007 | WO2007064818A1 Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064316A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 06/07/2007 | WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/07/2007 | WO2007063839A1 Cyclohexane derivative |
| 06/07/2007 | WO2007063789A1 Novel catechol derivative, pharmaceutical composition containing same, and uses of those |
| 06/07/2007 | WO2007044565A3 Composition and synthesis of new reagents for inhibition of hiv replication |
| 06/07/2007 | WO2007014290A3 Fungicidal carboxamides |
| 06/07/2007 | US20070129550 Amino acids with affinity for the alpha-2-delta-protein |
| 06/07/2007 | US20070129349 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2628817A1 Iminopropene compound and use thereof |
| 06/06/2007 | EP1792905A1 Product containing at least one phosphatase CDC25 inhibitor combined with at least one other anticancer agent |
| 06/06/2007 | CN1976710A Compounds and compositions as cathepsin S inhibitors |
| 06/06/2007 | CN1976693A Transthyretin stabilization |
| 06/06/2007 | CN1974562A Cycloprothrin amide compound containing quinary nitrogen heterocycle ketone and its prepn and application |
| 06/06/2007 | CN1974561A Cyhalothrin amide compound containing quinary nitrogen heterocycle ketone and its prepn and application |
| 06/06/2007 | CN1320049C Synergistic UV absorber combination |
| 06/06/2007 | CN1319954C Process for synthesizing benzoxazolinone compounds |
| 06/06/2007 | CN1319953C Method for preparing 2-trifluoro methyl benzoxazole |
| 06/06/2007 | CN1319952C Method for preparing oxazolidone amine |
| 06/05/2007 | US7226920 Aminotriazole compounds useful as inhibitors of protein kinases |
| 06/05/2007 | CA2376094C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (ppar) .alpha. |
| 05/31/2007 | WO2007062316A2 Trans-3,5-disubstitutedpyrrolidine: organocatalyst for anti-mannich reactions |
| 05/31/2007 | WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | WO2007060121A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
| 05/31/2007 | WO2007017687A3 Ep2 receptor agonists |
| 05/31/2007 | US20070123574 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
| 05/31/2007 | CA2630558A1 Catalyzed process of making c-5-substituted heterocyclic inhibitors of 11.beta.-hydroxy steroid dehydrogenase type 1 |
| 05/31/2007 | CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | CA2628538A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
| 05/30/2007 | EP1790338A1 Therapeutic agent for keratoconjunctiva disorder |
| 05/30/2007 | EP1789403A1 N-(phenyl-oxazol-4-ylmethoxymethyl)-cyclohexyl.succinic acid amide derivatives and related compounds which are used as ppar-ligands (peroxisome proliferator activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 05/30/2007 | EP1789402A1 2-{-3-2-(phenyl)-oxazol-4-ylmethoxymethyl!-cyclohexylmethoxy };-propionic acid derivatives used as ppar ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 05/30/2007 | EP1789394A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases |
| 05/30/2007 | EP1709014B1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 05/30/2007 | EP1003730B1 2-benzoyl-cyclohexane-1,3-diones |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1972897A Novel hexafluoroisopropanol derivatives |
| 05/29/2007 | US7223870 Coupling with ligand such as ethylenediamine, diaminocyclohexane |
| 05/29/2007 | US7223868 Heteroaromatic glucokinase activators |
| 05/29/2007 | US7223798 treating inflammatory or autoimmune disorders and pulmonary or respiratory tract inflammation |
| 05/29/2007 | US7223796 Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
| 05/24/2007 | WO2007058338A2 Oxazole compound and pharmaceutical composition |
| 05/24/2007 | WO2007030386A3 An improved process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol |
| 05/24/2007 | WO2007030385A3 A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol |
| 05/24/2007 | US20070117986 TRANS-3,5-DISUBSTITUTEDPYRROLIDINE: ORGANOCATALYST FOR anti-MANNICH REACTIONS |
| 05/24/2007 | US20070117985 in presence a complexes of transition metal and phosphine ligard, optimize yields and in a stereoselective manner to give enantiomerically enriched products; chemical intermediate for 4-(5-methyl-4-oxo-2-((S)-1 -(2-(trifluoromethyl)phenyl)ethylamino)-4,5-dihydrothiazol-5-yl)benzamide; diabetes, obesity |
| 05/24/2007 | US20070117852 (Hetero)cyclyl carboxanilides for controlling harmful fungi |
| 05/24/2007 | US20070117740 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners |
| 05/24/2007 | DE102005055892A1 Neue Kupplerkomponenten New Kupplerkomponenten |
| 05/24/2007 | CA2627541A1 Oxazole compound and pharmaceutical composition |
| 05/23/2007 | EP1787986A1 Hydroxamic acid derivative and medicine containing the same as active ingredient |
| 05/23/2007 | EP1786790A1 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | EP1181014B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 05/23/2007 | CN1968958A Method for producing optically active cyclopropanecarboxylic ester compound |
| 05/23/2007 | CN1966493A Amino acid derivative and its salts and solvate, its preparation method and uses |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/22/2007 | US7220871 taxane is prepared by esterifying an appropriate baccatin carrying a C-13 hydroxyl functional group with an acid derivative and is obtained by controlled saponification |
| 05/22/2007 | US7220864 Peroxisome proliferator activator controller; dietetics; antidiabetic agents; cardiovascular disorders; antidiabetic agents; hypoglycemic agents; antilipemic agenst |
| 05/22/2007 | US7220767 Pharmaceutical formulations containing zolmitriptan |
| 05/22/2007 | US7220745 Viricides; therapy for hepatitis virus infections |
| 05/22/2007 | CA2368347C Glucokinase activators |
| 05/18/2007 | WO2007056496A1 Oxazole and thiazole ppar modulator |
| 05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
| 05/18/2007 | WO2007056366A2 Compounds and compositions as ppar modulators |
| 05/18/2007 | WO2007055929A1 Cyclocarbonate-containing energy-curable compositions |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2006122020A3 Process for production of 4-biphenylyazetidin-2-ones |
| 05/18/2007 | CA2626483A1 Compounds and compositions as ppar modulators |
| 05/18/2007 | CA2626443A1 Oxazole and thiazole ppar modulators |
| 05/17/2007 | US20070112201 Intermediates to a copper bisoxazoline catalyst for asymmetric synthesis of agrochemical or pharmaceutical intermediates such as insecticides; reacting a cycloalkylidenemalonic diester with an aminoalcohol to form amide intermediate; cyclization to ligand e.g. 1,1-bis[2-[tert-butyloxazoline]]cyclopropane |
| 05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |